Skip to main content
Fig. 1 | BMC Pharmacology and Toxicology

Fig. 1

From: Therapeutic activity of sarpogrelate and dopamine D2 receptor agonists on cardiovascular and renal systems in rats with alloxan-induced diabetes

Fig. 1

Effect of the tested drugs on the hearts in alloxan-induced diabetic rats after four weeks of treatment. Triphenyl tetrazolium chloride stained cross-section of the heart of A Diabetic control rat showing uniform staining pattern. Both B bromocriptine treated group, and C cabergoline treated group showing a relative large pale, TTC-negative area of infarct. Both D Bromocriptine + sarbogrelate treated group, and E Cabergoline + sarbogrelate treated group showing a relative small pale, TTC-negative area of infarct

Back to article page

BMC Pharmacology and Toxicology

ISSN: 2050-6511

Contact us